Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.050
+0.060 (3.02%)
At close: Oct 31, 2025, 4:00 PM EDT
2.090
+0.040 (1.95%)
After-hours: Oct 31, 2025, 4:24 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $138.92 million as of October 31, 2025. Its market cap has decreased by -58.65% in one year.
Market Cap
138.92M
Enterprise Value
-47.85M
1-Year Change
-58.65%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $138.92M, a decrease of -65.55%. That is a compound annual growth rate of -22.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 138.92M | 14.80% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 773.39B |
| Johnson & Johnson | 453.65B |
| AbbVie | 385.89B |
| UnitedHealth Group | 306.75B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 214.23B |